There was an error in Table 1 of the article “A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated with Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion” by Hashim et al, which was published in the JDD August 2017 issue.1The corrected table is below.

References
- W. Hashim, J.K. Nia, D. Terrano, et al. A comparative study to evaluate epidermal barrier integrity of psoriasis patients treated with calcipotriene/betamethasone topical suspension versus betamethasone dipropionate 0.05% lotion. J Drugs Dermatol. 2017;16(8):747-752.